Acute respiratory infections and their complications
DOI:
https://doi.org/10.14739/2310-1210.2018.6.146777Keywords:
influenza, respiratory infectionsAbstract
The aim of the study is to summarize data on the epidemiological features, clinical manifestations and peculiarities of complications of influenza and other acute respiratory infections.
Materials and methods. The modern scientific literature about influenza and other ARVI was analysed.
Conclusions. At present the flu and other acute respiratory infections are the most common diseases that cause frequent epidemics and even pandemics and are an urgent matter worldwide. Influenza is dangerous for the elderly and infants in particular. The most recent data on the disease, peculiarities of its spreading, nature of epidemics in 2009 and 2016, characteristic clinical symptoms, main complications (pneumonia, acute respiratory distress syndrome, sinusitis) and their clinical aspects are presented. Influenza caused by a newCalifornia influenza A (H1N1) virus, which may cause pandemic outbreaks and is a typical emergent infection, is another topical issue. It should be noted that the new influenza A (H1N1) virus is rapidly spreading around the planet and can exchange genetic information with seasonal and avian influenza viruses. The mutation that originates in this case can significantly increase its pathogenic properties and make the mutant strain more aggressive.
References
WHO Influenza update, 2018. http://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en/.
Buchholz, U., Remschmidt, C., Heiden, an der M., Tolksdorf, K., et al. (2013). Acute respiratory infections and influenza-like illnesses: how many does a person have in a year? Options for the Control of Influenza VIII. (P. 251). Cape Town.
Wouters, E. F. M. (2002). Chronic obstructive pulmonary disease: systemic effects of COPD. Thorax, 57(12), 1067–1070.
Chertow, D. S., & Memoli, M. J. (2013). Bacterial coinfection in Influenza A. JAMA, 309(3), 275–82. doi: 10.1001/jama.2012.194139.
(2010). Centers for Disease Control and Prevention (CDC) Patients hospitalized with 2009 pandemic influenza A (H1N1) – New York City, May 2009 MMWR Morb. Mortal. Wkly Rep, 58(51), 1436–1440.
Ghedin, E., Fitch, A., Boyne, A., Griesemer, S., DePasse, J., Bera, J., et al. (2009). Mixed infection and the genesis of influenza virus diversity. J. Virol., 83(17), 8832–41. doi: 10.1128/JVI.00773-09.
Hoffmann, J., Perret, M., Ferraris, O., & Telles, J-N. (2013). The role of antigen presenting cells induced by influenza and pneumococcal coinfections: an in vitro model. Options for the Control of Influenza VIII, (P. 295). Cape Town.
Martin-Loeches, I., Sanchez-Corral, A., Diaz, E., Granada, R. M., Zaragoza, R., & Villavicencio, C. (2011). Community-acquired respiratory co-infection (CARC) in critically ill patients infected with pandemic 2009 influenza A (H1N1) virus infection. Chest, 139(3), 555–562. doi: 10.1378/chest.10-1396.
Abdullah Brooks, W. (2013). Paramyxovirus impact (RSV, HMPV, PIV) in children; New Studies of RVIs. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management. Proceedings of the Third ISIRV-Antiviral Group Conference. Tokyo.
Chertow, D. S., & Memoli, M. J. (2013). Bacterial coinfection in Influenza A. JAMA, 309(3), 275–282. doi: 10.1001/jama.2012.194139.
Besselaar, T. G., Lièvre, M., Drager Dayal, R., & Naidoo, D. (2013). WHO efforts on global capacity of influenza virus detection and antiviral susceptibility monitoring. Options for the Control of Influenza VIII, (P. 540). Cape Town.
WHO Global influenza Surveillance Network, 2009. Retrieved from http://www.who.int/csr/disease/influenza/surveillance/en/.
Kamps, B. S., Hoffmann, C., & Preiser, W. (Eds.). (2006). Influenza Report. Paris: Flying Publisher, Cagliari, Wuppertal, Sevilla.
Martin-Loeches, I., Sanchez-Corral, A., Diaz, E., Granada, R. M., Zaragoza, R., Villavicencio, C., et al. (2011). Community-acquired respiratory co-infection (CARC) in critically ill patients infected with pandemic 2009 influenza A (H1N1) virus infection. Chest, 139(3), 555–562. doi: 10.1378/chest.10-1396.
Mironenko, A., Onyshchenko, O., & Holubka, O. (2013) Іnfluenza sentinel surveillance in Ukraine and characteristics of isolates during the season 2012–2013. Options for the Control of Influenza VIII, (P. 636). Cape Town.
Zhou1, Y., Wu1, P., & Lau1 E. (2013). Influenza and risk of mortality among people with chronic medical conditions. Options for the Control of Influenza VIII, (P. 665–666). Cape Town.
Short, K. R., Diavatopoulos, D. A., Thornton, R., Pedersen, J., Strugnell, R. A., Wise, A. K., et al. (2011). Influenza virus induces bacterial and nonbacterial otitis media.. The J. of Infect. Dis, 204(12), 1857–1865. doi: 10.1093/infdis/jir618.
Shigeru Saito (2014). Influenza and Other RVIs in Pregnancy. Influenza and Other Respiratory Virus Infections: Advances in Clinical Management. Proceedings of the Third ISIRV-Antiviral Group Conference. Tokyo.
Novel coronavirus. ISIRV report. Retrieved from http://www.isirv.org/site/index.php/news/2-uncategorised/197-novel-coronavirus.
Mazick, A. (2013). Мortality Monitoring for public health action in Europe, EuroMOMO: an important tool for influenza surveillance and impact assessment, on behalf of the Network EuroMOMO. Options for the Control of Influenza VIII, (P. 237). Cape Town.
Huang, C. L., Nguyen, P.A., Kuo, P.L., Iqbal, U., Hsu, Y.H., Jian, W.S. (2013). Influenza vaccination and reduction of risk in ischemic heart disease among chronic obstructive pulmonary elderly. Computer Methods and Programs in Biomedicine, 111(507), 511.https://doi.org/10.1016/j.cmpb.2013.05.006
Thomson, A. (2005). The Cytokine Handbook. London: Acad. Press.
Bauer, T. T., Montón, C., Torres, A., Cabello, H., Fillela, X., Maldonado, A., et al. (2000). Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax, 55(1), 46–52. doi: [10.1136/thorax.55.1.46].
Chollet-Martin, S., Rousset, F., & Chastre, J. (1996). Cytokines in adult respiratory distress syndrome. Lancet, 344, 1440.
Strum, J. A. (2015). Adult respiratory Distress Syndrome. Berlin, Hiedelberg.
Nekrasov, L. S., Escort, V. M., Dihanovska, T. A. (2016). Flu and ADVI in Ukraine: Newsletter.
Gorbea, C., Makar, K. A., Pauschinger, M., Pratt, G., Bersola, J. L., Varela, J., et al. (2010). Role for Toll-like Receptor 3 Variants in Host Susceptibility to Enteroviral Myocarditis and Dilated Cardiomyopathy. Journal of Biological Chemistry, 285(30), 23208–23. doi: 10.1074/jbc.M109.047464.
Rothberg, M. B., Haessler, S. D., & Brown, R. B. (2008). Complications of Viral Influenza. The American Journal of Medicine, 121(4), 258–64. doi: 10.1016/j.amjmed.2007.10.040.
Almond, M. H., McAuley, D. F., Wise, M. P., & Griffiths, M. J. (2012). Influenza-related pneumonia. Clin. Med., 12(1), 67-70. doi: 10.7861/clinmedicine.12-1-67.
Rello, J., & Pop-Vicas, A. (2009). Clinical review: Primary influenza viral pneumonia. Critical Care, 13(6), 235. doi: 10.1186/cc8183.
Ruuskanen, O., Lahti, E., & Jennings, L. C. (2011). Viral pneumonia. Lancet, 377, 1264–1275. doi: 10.1016/S0140-6736(10)61459-6
Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., & Bautista, E. (2009). Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N. Engl. J. Med., 361(7), 680–9. doi: 10.1056/NEJMoa0904252.
Centers for Disease Control and Prevention (CDC). (2009). Hospitalized patients with novel influenza A (H1N1) virus infection – California, April – May, 2009. MMWR Morb Mortal Wkly Rep., 58(19), 536–41.
Dawood, F. S., Jain, S., Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., et al. (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med., 360(25), 2605–15. doi: 10.1056/NEJMoa0903810.
Domínguez-Cherit, G., Lapinsky, S. E., Macias, A. E., Pinto, R., Espinosa-Perez, L., de la Torre, A., et al. (2009). Critically ill patients with influenza A (H1N1 novel) in Mexico. JAMA, 302(17), 1880–7. doi: 10.1001/jama.2009.1536.
(2010) The Ministry of health of Ukraine/information on the incidence of influenza and acute respiratory diseases and their complications (pneumonia, etc.) for the period from 22 to 28 March (12-week) 2010. Retrieved from http://www.moz.gov.ua/ua/main/press/?docID = 15184.
Pandemic H1N1 2009 influenza: clinical management guidelines for adults and children. – 2009. Retrieved from www.dh.gov.uk/en/Publichealth/Flu/Swinefluguidance/DH_122629
Van der Sluijs, K. F., Van der Poll, T., Lutter, R., Juffermans, N. P., & Schultz, M. J. (2010). Bench-to-bedside review: Bacterial pneumonia with influenza-pathogenesis and clinical implications. Critical Care, 14(2), 219–227. doi: 10.1186/cc8893.
Murray, R. J., Robinson, J. O., White, J. N., Hughes, F., Coombs, G.
Murray, R. J., Robinson, J. O., White, J. N., Hughes, F., Coombs, G.W., Pearson, J. C., et al. (2010). Community-Acquired Pneumonia Due to Pandemic A (H1N1) 2009. Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection. PLoS ONE, 5(1), e8705. doi: 10.1371/journal.pone.0008705.
Geddes, A. (2009). Influenza and bacterial pneumonia International. Journal of Antimicrobial Agents., 34(4), 293–294.10.1016/j.ijantimicag.2009.06.004
Diavatopoulos, D. A., Short, K. R., Price, J. T., Wilksch, J. J., Brown, L. E., Briles, D. E., et al. (2010). Influenza A virus and Streptococcus pneumoniae facilitates disease transmission. The FASEB Journal, 24(6), 1789–98. doi: 10.1096/fj.09-146779.
(2009).Centers for Disease Control and Prevention (CDC): Bacterial co infections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) United States, May-August 2009. MMWR Morb. Mortal Wkly Rep., 58, 1071–1074.
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008). The Predominant role of bacterial pneumonia as a cause of death in influenza pandemic: implications for pandemic influenza preparedness. J. Infect. Dis., 198(7), 962–70. doi: 10.1086/591708.
Mamas, M. A., Fraser, D., & Neyses, L. (2008). Cardiovascular manifestations associated with influenza virus infection. Int. J. Cardiol., 130(3), 304–9. doi: 10.1016/j.ijcard.2008.04.044.
(2009). National Center for Immunization and Respiratory Diseases (2009) Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep., 58, 1–8.
Van Kerkhove, M. D., Vandemaele, K. A., Shinde, V., Jaramillo-Gutierrez, G., Koukounari, A., Donnelly, C. A., et al. (2011). Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med., 8(7), e1001053. doi: 10.1371/journal.pmed.1001053.
Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J., & Fukuda, K. (1998). Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis., 178, 53–60. doi: https://doi.org/10.1086/515616.
Dawood, F. S., Jain, S., & Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., et al. (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med., 360(25), 2605–15. doi: 10.1056/NEJMoa0903810.
Centers for Disease and Prevention (CDC). (2009). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal Wkly Rep., 58(19), 521–4.
Domínguez-Cherit, G., Lapinsky, S. E., Macias, A. E., Pinto, R., Espinosa-Perez, L., de la Torre, A., et al. (2009). Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA, 302(17), 1880–7. doi: 10.1001/jama.2009.1536.
Salihefendic, N., Zildzic, M., & Ahmetagic, S. (2015). Acute Respiratory Distress Syndrome (ARDS) from Endemic Influenza A/H1N1: Prehospital Management. Med Arch., 69(1), 62–3. doi: 10.5455/medarh.2015.69.62-63.
Pearlman, A. N., & Conley, D. B. (2008). Review of current guidelines related to the diagnosis and treatment of rhinosinusitis. Curr. Opin. Otolaryngology, Head Neck Surg., 16(3), 226–230. doi: 10.1097/MOO.0b013e3282fdcc9a.
Autio, T. J., Tapiainen, T., Koskenkorva, T., Närkiö, M., Lappalainen, M., Nikkari, S., et al. (2015). The role of microbes in the pathogenesis of acute rhinosinusitis in young adults. Laryngoscope, 125(1), E1–7. doi: 10.1002/lary.24862.
Schied, D. C., & Hamm, R. M. (2006). Ostryj bakterial'nyj rinosinusit u vzroslyh. Obzor. Medicina neotlozhnykh sostoyanij, 5(6), 44–54. [in Russian].
Aniutin, R., Kulikov, L., & Nersesyan, M. (2005). Morfologicheskie osobennosti slizistoj obolochki klinovidnoj pazukhi u bol'nykh sfenoiditom [Morphological features of the sphenoid sinus mucosa in patients with sphenoiditis]. Rossiyskaya rinologiya, 4, 21–22. [in Russian].
Andreichyn, Yu. M. (2015) Patohenetychni osoblyvosti perebihu verkhnoshchelepnykh synusytiv i remodeliuvannia synusnykh stinok (Avtoref. dis… dokt. med. nauk) [Pathogenetic features of the flow of maxillary sinusitis and remodeling of sinus walls. Dr. med. sci. diss.]. Ternopil. [in Ukrainian].
Lima, J. T., Paula, F. E., Proença-Modena, J. L., Demarco, R. C., Buzatto, G. P., Saturno, T. H., et al. (2015). The seasonality of respiratory viruses in patients with chronic rhinosinusitis. Am. J. Rhinol. Allergy, 29(1), 19–22. doi: 10.2500/ajra.2015.29.4129.
Rowan, N. R., Lee, S., Sahu, N., Kanaan, A., Cox, S., Phillips, C. D., & Wang, E. W. (2015). The role of viruses in the clinical presentation of chronic rhinosinusitis. Am. J. Rhinol. Allergy., 29(6), e197-200. doi: 10.2500/ajra.2015.29.4242.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
